Effects of an oral MMP-9 and-12 inhibitor, AZD1236, on biomarkers in moderate/severe COPD: A randomised controlled trial

Ronald Dahl, Ingrid Titlestad, Ari Lindqvist, Pascal Wielders, Heather Wray, Millie Wang, Viktoria Samuelsson, John Mo, Alison Holt

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalPulmonary Pharmacology & Therapeutics
Volume25
Issue number2
Pages (from-to)169-177
Number of pages9
ISSN1094-5539
DOIs
Publication statusPublished - 2012
MoE publication typeA1 Journal article-refereed

Fields of Science

  • COPD
  • Matrix metalloproteinases
  • Biomarkers
  • Desmosine
  • Lymphocytes
  • OBSTRUCTIVE PULMONARY-DISEASE
  • MATRIX METALLOPROTEINASES
  • SYSTEMIC INFLAMMATION
  • LUNG-FUNCTION
  • DESMOSINE
  • EXACERBATION
  • SPUTUM
  • CELLS
  • TIME
  • 3121 General medicine, internal medicine and other clinical medicine

Cite this